In this episode of All Things Disciplined Agile (ATDA), Joshua Barnes was joined by Kamil Mroz, Director, Program Management Lead Gene Therapy at UCB, sharing his lessons learned on agile in pharma. Adopting agile ways of working in an industry where the product development cycle often spans 10-15 years is quite unique. Hear what worked, what didn’t, and what is still being experimented on.
Are you a PMI member? You can claim 0.5 hours for your PMI renewal- PMI PDU Claim Code 49723ERCLI.
Joshua Barnes is the Founder of Process Mentors, Inc, a PMI Authorized Training and Consulting Partner. Joshua is a Disciplined Agile Coach (DAC) and Disciplined Agile Value Stream Consultant (DAVSC) and DASM/DASSM/DAVSC/DAC Instructor. He is a recognized leader in virtual training and coaching and has trained thousands of people, in both co-located as well as virtual live formats on their Disciplined Agile journey.
Kamil Mroz, Director, Program Management Lead Gene Therapy at UCB, focused on creating value in early drug development through project/program management in the field of immunology and neurology to serve patients in need (with a focus on AAV-mediated Gene Therapy). I am passionate about coaching, mentoring, and leading teams to reach their full potential through overcoming complex organizational challenges and transformations.
The All Things Disciplined Agile LinkedIn Group provides the Disciplined Agile community a place to share, discuss, debate, and ask questions on anything related to Disciplined Agile. It is supported by the community, for the community including DA partners, coaches, instructors, and practitioners. It is freely open to anyone.